Pure phosphofructokinase (ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) from liver is strong y inhibited by ATP, whereas crude phosphofructokinase is only slightly inhibited by ATP. A factor that is removed from the enzyme during purification and can prevent the inhibition of phosphofructokinase by ATP has been isolated. The factor can be resolved into three components that differ in molecular weights, as shown by gel filtration on Sephadex G-25. These factors overcome the ATP inhibition but have no effect on the catalytic activity under the optimum assay conditions. Furthermore, AMP acts synergistically with the activation factor in reversing ATP inhibition. It is proposed that the activation of phosphofructokinase by the activation factor and AMP is sufficient to account for the glycolytic flux in the liver. Phosphofructokinase (ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) is one of the regulatory enzymes of glycolysis in mammalian tissues, and its activity is controlled by a variety of metabolites (reviewed in ref. 1). The liver enzyme has been obtained in homogeneous forms from various sources (2-6), and the kinetic as well as the allosteric properties of the isolated enzymes have been investigated. The effectors, which include ATP and citrate as inhibitors and AMP and fructose-1,6-P2 as activators are considered to be important in the regulation of phosphofructokinase in the liver. Recent studies by Reinhart and Lardy (6) using a homogeneous preparation of phosphofructokinase isolated from rat liver showed that the apparent Km for fructose-6-P is 6 mM in the presence of 3 mM ATP under near-physiological conditions of pH and salt. These results indicate that the enzyme may be essentially inactive in vivo, because the physiological concentrations of fructose-6-P and ATP are approximately 0.02-0.04 mM and 3 mM, respectively. We have obtained similar results by using purified phosphofructokinase isolated from rat liver. The activators AMP and fructose-1,6-P2 are present in liver at concentrations of approximately 0.1 mM (1 gM in cytoplasm) and 20,gM (7), respectively, which would reverse the ATP inhibition to some extent. However, activation by these effectors is not enough to account for the known overall glycolytic rate in the liver.During our attempts to purify the enzyme from rat liver, we observed that the ATP inhibition of the enzyme changed after each fractionation, while the activity, assayed under optimal conditions, remained constant (aside from the usual mechanical loss of the enzyme). Thus, we have investigated the factor that produces changes in the ATP sensitivity with increasing purity of the enzyme. Dunaway and Segal (8,9) have isolated a peptide (Mr = 3500) that stabilizes phosphofructokinase against thermal and lysosomal inactivation and has a concentration in liver that varies according to the dietary conditions of the animal. In this report, we present results that suggest the existence The publication costs of this article were defrayed in part by pa...